枸地氯雷他定与阿伐斯汀递减疗法治疗慢性荨麻疹的临床观察
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Clinical Observation of the Treatment of Chronic Urticaria with Desloratadine and Diminishing Avastin
  • 作者:于淼
  • 英文作者:Yu Miao;Jinzhou National Health Guarantee Center;
  • 关键词:慢性荨麻疹 ; 枸地氯雷他定 ; 阿伐斯汀递减疗法
  • 英文关键词:chronic urticaria;;desloratadine;;diminishing avastin therapy
  • 中文刊名:JZYX
  • 英文刊名:Journal of Jinzhou Medical University
  • 机构:锦州市全民健康保障中心;
  • 出版日期:2019-08-13
  • 出版单位:锦州医科大学学报
  • 年:2019
  • 期:v.40
  • 语种:中文;
  • 页:JZYX201904024
  • 页数:3
  • CN:04
  • ISSN:21-1606/R
  • 分类号:79-80+94
摘要
目的探究慢性荨麻疹患者临床治疗中枸地氯雷他定与阿伐斯汀递减疗法的临床应用效果。方法将我院2017年10月至2018年9月收治的76例慢性荨麻疹患者作为本次研究对象,按照入院顺序分两组,各38例,对照组使用阿伐斯汀递减疗法治疗,研究组使用枸地氯雷他定进行治疗,分组对比患者临床治疗效果、治疗前后症状体征积分及血浆组胺水平。结果研究组患者临床治疗效果明显优于对照组,研究组患者治疗后症状体征积分及血浆组胺水平均优于对照组,差异有统计学意义(P<0. 05)。结论慢性荨麻疹患者临床治疗中使用枸地氯雷他定能够有效提升治疗效果,改善患者临床症状,平衡患者血浆组胺水平,临床应效果更佳。
        Objective To explore the clinical effect of desloratadine and diminishing avastin therapy in the treatment of chronic urticaria. Methods 76 patients with chronic urticaria admitted to our hospital from October 2017 to September 2018 were selected as the research subjects and divided into two groups,with 38 patients in each group. The control group was treated with diminishing avastin therapy and the study group were treated with desloratadine. The treatment effect,symptom and sign scores before and after treatment and plasma histamine levels were compared. Results The clinical treatment effect of the study group was significantly better than that of the control group,and the symptoms and signs scores and plasma histamine levels of the study group after treatment were better than that of the control group,with statistically significant difference( P< 0. 05). Conclusion Desloratadine can effectively enhancethe therapeutic effect,improve the clinical symptoms and balance the plasma histamine levels of patients with chronic urticaria.
引文
[1]孟庆丽.枸地氯雷他定递减疗法对慢性荨麻疹患者血清免疫球蛋白水平的影响[J].临床研究,2017,25(3):132-133.
    [2]蒙金秋,蒙安定,简华慧,等.枸地氯雷他定与自血疗法联合治疗自身免疫性荨麻疹的疗效观察[J].右江医学,2017,45(1):81-84.
    [3]李金辉.枸地氯雷他定用于慢性荨麻疹患者治疗中的临床效果[J].临床医药文献电子杂志,2017,4(6):1126.
    [4]沈建国,陆维敏,胡晗峰.枸地氯雷他定片辅助治疗慢性荨麻疹的临床疗效分析[J].中国医师杂志,2017,19(1):121-123.
    [5]许铮.枸地氯雷他定与依匹斯汀治疗慢性荨麻疹的疗效对比[J].医学临床研究,2016,33(2):361-362.
    [6]董东,何小亮,杨德勇,等.枸地氯雷他定与阿伐斯汀递减疗法治疗慢性荨麻疹的疗效比较[J].中国药房,2015,26(36):5078-5080.
    [7]夏华.枸地氯雷他定联合玉屏风颗粒序贯治疗慢性荨麻疹的临床观察[J].中国中西医结合皮肤性病学杂志,2018,17(5):55-57.
    [8]谭全邦,喻洪芝,张俊豪.麻黄附子细辛汤联合枸地氯雷他定片治疗慢性荨麻疹对血清总Ig E水平的影响[J].现代中西医结合杂志,2015,24(29):3251-3253.
    [9]陈慧,李季,孙澍彬.百癣夏塔热胶囊联合枸地氯雷他定治疗慢性荨麻疹的临床研究[J].现代药物与临床,2018,33(3):587-591.
    [10]张治成,杨晓,杨晓刚.意守式针灸疗法联合枸地氯雷他定治疗中重度间歇性过敏性鼻炎临床疗效及预后分析[J].重庆医学,2016,45(25):3542-3544.
    [11]李国邦,薛强东,唐祁平.地氯雷他定联合复方甘草酸苷治疗慢性荨麻疹的临床观察[J].医学研究杂志,2015,44(1):150-153.
    [12]由丽娜,陈丽蓉,宋国宏,等.足三里穴位自血疗法联合地氯雷他定治疗胆碱能性荨麻疹的临床观察[J].中国现代医学杂志,2016,26(17):72-74.
    [13]陈阳静,李宏慧,赵瑞敏,等.鼻舒适片联合枸地氯雷他定治疗过敏性鼻炎的临床研究[J].现代药物与临床,2016,31(4):525-528.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700